Volume 14, Number 6—June 2008
Research
Tuberculosis from Mycobacterium bovis in Binational Communities, United States
Timothy C. Rodwell*
, Marisa Moore†‡, Kathleen S. Moser†, Stephanie K. Brodine§, and Steffanie A. Strathdee*
, Marisa Moore†‡, Kathleen S. Moser†, Stephanie K. Brodine§, and Steffanie A. Strathdee*
Table 2
Univariate comparison of Mycobacterium bovis cases relative to M. tuberculosis cases, San Diego County, California, 2001–2005*
| Characteristic | No. (%)†M. bovis cases, n = 132 | No. (%)† M. tuberculosis cases, n = 1,192 | Univariate p value |
|---|---|---|---|
| Sex | 0.15 | ||
| M | 75 (56.8) | 754 (63.2) | |
| F |
57 (43.2) |
438 (36.7) |
|
| Age group, y | <0.001 | ||
| 0–4 | 15 (11.4) | 10 (0.8) | |
| 5–14 | 14 (10.6) | 15 (1.3) | |
| 15–24 | 21 (15.9) | 156 (13.1) | |
| 25–44 | 46 (34.8) | 409 (34.3) | |
| 45–64 | 20 (15.2) | 356 (29.9) | |
| >64 |
16 (12.1) |
246 (20.6) |
|
| Race/ethnicity | <0.001‡ | ||
| Hispanic | 128 (96.9) | 529 (44.3) | |
| White | 3 (2.27) | 151 (12.6) | |
| Asian | 1 (0.75) | 420 (35.2) | |
| Black | 0 | 86 (7.2) | |
| Other |
0 |
6 (1.0) |
|
| Country of birth | <0.001 | ||
| Mexico | 79 (59.8) | 382 (32.0) | |
| United States | 53 (40.2) | 302 (25.3) | |
| Philippines | 0 | 248 (20.8) | |
| Other |
0 |
260 (21.8) |
|
| Previous TB | 0.52 | ||
| Yes | 5 (3.8) | 60 (5.0) | |
| No | 127 (96.2) | 1128 (94.6) | |
| Unknown§ |
0 |
4 (0.3) |
|
| Sputum AFB smear result | 0.16 | ||
| Positive | 40 (30.3) | 590 (49.4) | |
| Negative | 43 (32.5) | 461 (38.6) | |
| Not done§ |
49 (37.1) |
141 (11.8) |
|
| Disease site | <0.001 | ||
| Pulmonary | 71 (53.7) | 1031 (86.4) | |
| Extrapulmonary |
61 (46.2) |
161 (13.5) |
|
| Clinical manifestations | <0.001 | ||
| Single site disease | 84 (63.6) | 1036 (86.9) | |
| Multisite disease |
48 (36.4) |
156 (13.1) |
|
| Chest radiograph lesions | <0.001 | ||
| No lesions | 55 (41.7) | 123 (10.3) | |
| Pulmonary lesions consistent with TB | 75 (56.8) | 1063 (89.2) | |
| Unknown§ |
2 (1.5) |
6 (0.5) |
|
| HIV status | <0.001 | ||
| Negative | 48 (36.4) | 611 (51.3) | |
| Positive | 33 (25.0) | 107 (9.0) | |
| Unknown |
51 (38.6) |
474 (39.8) |
|
| Treatment outcome | 0.02 | ||
| Died before treatment completed | 19 (14.3) | 91 (7.6) | |
| Alive at end of treatment | 102 (77.2) | 913 (76.5) | |
| Unknown | 11 (8.3) | 188 (15.7) |
*TB, tuberculosis; AFB, acid-fast bacillus.
†Percentages do not always add up to 100% due to rounding.
‡Fisher exact p value.
§Not included in χ2 calculation.
Page created: July 09, 2010
Page updated: July 09, 2010
Page reviewed: July 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.